What are the game-changing drugs for myeloma right now?
In this video, Dr. Brian G.M. Durie sheds light on two or three new agents that may be effective to optimally treat myeloma.
BOTTOM LINE:
Many new therapies could be game-changers, but it will take time to know which work best.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.
Previous Post
What is the value of ASCT if my myeloma protein level is already zero?
Next Post
IMWG Conference Series - Copenhagen 2016: How do you sequence new therapies?